Dambkowski Carl
CIK 0001983476
Chief Medical OfficerDirector
Filings
31
Latest Jun 3, 2026
Issuers covered
2
Showing
31 of 31
Page 1
Track record
51 of 56 open-market trades scored (91% price coverage) - 5 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 51 | 41% | -4.1% | -4.5% | +21.2% | -43.7% |
| 90 days | 48 | 35% | -12.8% | -8.9% | +41.6% | -92.4% |
| 180 days | 36 | 44% | -19.4% | -5.3% | +33.6% | -99.9% |
| 365 days | 24 | 38% | -44.6% | -47.7% | +29.6% | -149.0% |
Issuers
Companies where Dambkowski Carl has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 27 | May 8, 2026 |
| ORKA | Oruka Therapeutics, Inc. | 4 | Jun 3, 2026 |
All filings
31 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|